FTSV Insider Trading Activity and SEC Form 4 Filings
FTSV insider trading summary
No open-market insider purchases or sales of Forty Seven, Inc. (FTSV) have been reported on SEC Form 4 in the past 12 months.
Latest FTSV insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 1, 2020 | Chris H Takimoto | Chief Medical Officer | Sell | $7.6M (79,195 @ $95.42) |
| Apr 1, 2020 | Mark Anthony McCamish | President and CEO | Sell | $223K (2,340 @ $95.41) |
| Apr 1, 2020 | Ann D Rhoads | Chief Financial Officer | Sell | $184K (1,924 @ $95.42) |
| Apr 1, 2020 | Mark Anthony McCamish | President and CEO | Sell | $2.9M (30,237 @ $95.42) |
| Mar 12, 2020 | Irving Weissman | Director | Sell | $3.9M (42,095 @ $93.29) |
| Mar 12, 2020 | Irving Weissman | Director | Sell | $19K (200 @ $93.74) |
| Mar 12, 2020 | Irving Weissman | Director | Sell | $996K (10,800 @ $92.19) |
| Mar 11, 2020 | Irving Weissman | Director | Sell | $18.7M (196,905 @ $94.72) |
| Feb 18, 2020 | Ravindra Majeti | Director | Sell | $516K (11,420 @ $45.17) |
| Feb 18, 2020 | Ravindra Majeti | Director | Sell | $17K (375 @ $45.87) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.